These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30324580)

  • 1. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.
    Jankowski RJ; Tu LM; Carlson C; Robert M; Carlson K; Quinlan D; Eisenhardt A; Chen M; Snyder S; Pruchnic R; Chancellor M; Dmochowski R; Kaufman MR; Carr L
    Int Urol Nephrol; 2018 Dec; 50(12):2153-2165. PubMed ID: 30324580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the effects of autologous muscle-derived cell injections on urethral sphincter morphometry using 3D/4D ultrasound.
    Ismail S; Morin M; Tu LM
    World J Urol; 2020 Nov; 38(11):2881-2889. PubMed ID: 31938840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary application of autologous muscle-derived cells for urinary sphincter regeneration.
    Kaufman MR
    World J Urol; 2020 Sep; 38(9):2095-2099. PubMed ID: 31834471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous muscle derived cells for treatment of stress urinary incontinence in women.
    Peters KM; Dmochowski RR; Carr LK; Robert M; Kaufman MR; Sirls LT; Herschorn S; Birch C; Kultgen PL; Chancellor MB
    J Urol; 2014 Aug; 192(2):469-76. PubMed ID: 24582537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.
    Winkler H; Jacoby K; Kalota S; Snyder J; Cline K; Robertson K; Kahan R; Green L; McCammon K; Rovner E; Rardin C
    Female Pelvic Med Reconstr Surg; 2018; 24(3):222-231. PubMed ID: 28953076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study.
    Carr LK; Robert M; Kultgen PL; Herschorn S; Birch C; Murphy M; Chancellor MB
    J Urol; 2013 Feb; 189(2):595-601. PubMed ID: 23260547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of male stress urinary incontinence using autologous adipose-derived regenerative cells: Long-term efficacy and safety.
    Gotoh M; Yamamoto T; Shimizu S; Matsukawa Y; Kato M; Majima T; Takai S; Funahashi Y; Toriyama K
    Int J Urol; 2019 Mar; 26(3):400-405. PubMed ID: 30557919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic stimulation for stress urinary incontinence: study protocol for a randomized controlled trial.
    Lim R; Liong ML; Leong WS; Khan NA; Yuen KH
    Trials; 2015 Jun; 16():279. PubMed ID: 26093910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of electroacupuncture for women with pure stress urinary incontinence: study protocol for a multicenter randomized controlled trial.
    Liu Z; Xu H; Chen Y; He L; Liu J; Yan S; Du R; Wu J; Liu B
    Trials; 2013 Sep; 14():315. PubMed ID: 24079823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy].
    Cornu JN; Doucet C; Sèbe P; Ciofu C; Gil Diez de Medina S; Vallancien G; Amarenco G; Cussenot O; Pinset C; Haab F
    Prog Urol; 2011 Nov; 21(12):859-65. PubMed ID: 22035912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study.
    Sharifiaghdas F; Tajalli F; Taheri M; Naji M; Moghadasali R; Aghdami N; Baharvand H; Azimian V; Jaroughi N
    Int J Urol; 2016 Jul; 23(7):581-6. PubMed ID: 27062371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study.
    Sokol ER; Karram MM; Dmochowski R
    J Urol; 2014 Sep; 192(3):843-9. PubMed ID: 24704117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
    Takahashi S; Kato K; Yokoyama O; Takei M; Gotoh M
    J Urol; 2024 Aug; 212(2):267-279. PubMed ID: 38979756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral injection of autologous muscle precursor cells for treatment of female stress urinary incontinence: a prospective phase I clinical trial.
    Schmid FA; Prange JA; Kozomara M; Betschart C; Sousa RA; Steinke N; Hunziker M; Lehner F; Veit M; Grossmann R; Landsmann A; Hötker AM; Boss A; Mohr-Haralampieva D; Eberli D
    Int Urogynecol J; 2023 Sep; 34(9):2197-2206. PubMed ID: 37042972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence.
    Dmochowski RR; Rovner ES; Connors KG; Winters JC
    Neurourol Urodyn; 2018 Nov; 37(8):2919-2927. PubMed ID: 30203494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of electroacupuncture for the treatment of simple female stress urinary incontinence - comparison with pelvic floor muscle training: study protocol for a multicenter randomized controlled trial.
    Su T; Zhou J; Liu Z; Chen Y; Zhang W; Chu H; Luo Q; Lu J; An J; Liu B
    Trials; 2015 Feb; 16():45. PubMed ID: 25887231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial.
    Strasser H; Marksteiner R; Margreiter E; Pinggera GM; Mitterberger M; Frauscher F; Ulmer H; Fussenegger M; Kofler K; Bartsch G
    Lancet; 2007 Jun; 369(9580):2179-2186. PubMed ID: 17604800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.
    Kaufman MR; Goldman HB; Chermansky CJ; Dmochowski R; Kennelly MJ; Peters KM; Quiroz LH; Bennett JB; Thomas S; Marguet CG; Benson KD; Lee UJ; Sokol ER; Wolter CE; Katz DM; Tarnay CM; Antosh D; Heit MH; Rehme C; Karram M; Snyder S; Canestrari E; Jankowski RJ; Chancellor MB
    Neurourol Urodyn; 2024 Nov; 43(8):2290-2299. PubMed ID: 39282854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon.
    McCammon K; Jacoby K; Kalota S; Snyder J; Cline K; Robertson K; Rardin C; Kahan R; Green L; Zuckerman J; Rovner E
    Neurourol Urodyn; 2018 Jan; 37(1):440-448. PubMed ID: 29095516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the noradrenaline reuptake inhibitor, TAS-303, in women with stress urinary incontinence: Results of a double-blind, randomized, placebo-controlled, early phase II trial.
    Takahashi S; Kato K; Takei M; Yokoyama O; Gotoh M
    Int J Urol; 2021 Jan; 28(1):82-90. PubMed ID: 33145841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.